Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Funding Amount
Up to $900,000
Deadline
May 16, 2028
589 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Higher Education InstitutionsPublic/State Controlled Institutions of Higher Education.
- Private Institutions of Higher Education.
- Nonprofits Other Than Institutions of Higher Education.
- Small BusinessesFor-Profit Organizations (Other than Small Businesses)Local Governments.
- County Governments.
- Special District GovernmentsIndian/Native American Tribal Governments (Federally Recognized)Indian/Native American Tribal Governments (Other than Federally Recognized)Federal Governments U.S.
- Independent School Districts.
- Native American Tribal Organizations (other than Federally recognized tribal governments)Faith-based or Community-based Organizations.
Required status
- 501(c)(3) tax-exempt status
Other requirements
- Eligible Organizations.
- State Governments.
- City or Township Governments.
- Territory or PossessionOther.
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Details
- Agency: Food and Drug Administration
- Department: Department of Health and Human Services
- Opportunity #: RFA-FD-25-020
- Instrument: grant
Eligibility
Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)For-Profit OrganizationsSmall BusinessesFor-Profit Organizations (Other than Small Businesses)Local GovernmentsState GovernmentsCounty GovernmentsCity or Township GovernmentsSpecial District GovernmentsIndian/Native American Tribal Governments (Federally Recognized)Indian/Native American Tribal Governments (Other than Federally Recognized)Federal Governments U.S. Territory or PossessionOtherIndependent School DistrictsPublic Housing Authorities/Indian Housing AuthoritiesNative American Tribal Organizations (other than Federally recognized tribal governments)Faith-based or Community-based OrganizationsRegional OrganizationsNo
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
Amount
Up to $250,000
Deadline
January 29, 2027
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Food and Drug Administration
Amount
Up to $200,000
Deadline
April 1, 2027
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Food and Drug Administration
Amount
Up to $300,000
Deadline
April 1, 2027
Laboratory Flexible Funding Model (LFFM)
Food and Drug Administration
Amount
Up to $1,500,000
Deadline
January 11, 2028
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Food and Drug Administration
Amount
Up to $600,000
Deadline
February 8, 2028
Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration
Amount
Up to $1,250,000
Deadline
May 12, 2028
Ready to apply for Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required). Now let's win it.